Entity
  • Apollo Therapeutics

  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    5,805
  • Entity types

  • Location

    Stevenage, UK

    Stevenage

    United Kingdom

  • Employees

    Scale: 51-200

    Estimated: 58

  • Engaged corporates

    3
    1 0
  • Added in Motherbase

    1 year, 2 months ago
Description
  • Value proposition

    A transformative idea for transformative medicines

    Apollo Therapeutics is a biopharmaceutical company rapidly advancing a robust pipeline of potentially transformative therapeutic programs based on breakthrough discoveries. Through deep relationships with world-leading universities and scientists, the company identifies programs with strong biological hypotheses and potential to become meaningful new treatment options. Apollo’s portfolio-based model combines a centralized team of drug development ‘architects’ and subject matter experts who are able to rigorously evaluate therapeutic programs in an objective, data-driven manner – prioritizing critical experiments to de-risk programs early. This capital efficiency allows Apollo to focus on scaling a robust and potentially transformative pipeline, with over 15 therapeutic programs in development today across oncology, major inflammatory disorders and rare disease.

    Apollo’s innovative model was created in late 2015 by three world-leading universities Cambridge, Imperial College London and University College London in partnership with AstraZeneca, GlaxoSmithKline and Johnson & Johnson Innovation. There is significant opportunity ahead of us to bring new treatments to market as our lead programs move into clinical development. We will look to build on our existing collaborations, foster new relationships with additional top academics around the world and in-license drug candidates from new partners.

    Apollo is funded by Patient Square Capital, Rock Springs Capital, Reimagined Ventures and UCL Technology Fund. We are expanding our operations in Cambridge, UK and Boston, USA.

    For more information, please visit our website at www.apollotherapeutics.com

    Biotechnology, biopharmaceuticals, therapeutics, oncology, major inflammatory disorders, and rare disease

  • Breakthrough science | Portfolio business | Apollo Therapeutics

    Portfolio biopharmaceutical company. Welcome to Apollo Therapeutics learn about us, our investors and our team

  • https://www.apollotx.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Cambridge Enterprise
Cambridge Enterprise
Startup accelerator & VC, Higher Education
Cambridge Enterprise
Startup accelerator & VC, Higher Education
Other

30 Sep 2024


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

30 Sep 2024


Oxford University Innovation
Oxford University Innovation
Research, Financial Services
Oxford University Innovation
Research, Financial Services
Other

17 Nov 2024


Similar entities
Loading...
Loading...
Social network dynamics